Electroencephalography (EEG) Devices Market Size, Status And Industry Outlook During 2023 To 2029 By Key Players | Nonin Medical , Inc. , Nihon Kohden Corporation , Headsense Medical

Latest Study on Industrial Growth of electroencephalography (eeg) devices market 2023-2029. A detailed study accumulated to offer Latest insights about acute features of the Electroencephalography (EEG) Devices Market. The report contains different market predictions related to revenue size , production, CAGR, Consumption, gross margin, price , and other substantial factors . While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The market includes news and updates about the market current situation, historic data, present market trends , and this factor which is valuable and supportive to the business. It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary and SWOT analysis . The report aims to supply a further illustration of the newest scenario, economic slowdown , and COVID-19 impact on the overall industry.

The Electroencephalography (EEG) Devices market is anticipated to register an expansion at a CAGR of 10.3% during the forecast period, 2023–2029.

Download Free Sample Report PDF (Including Full TOC, Table & Figures):

Key Players in This Report Include:

Nonin Medical, Inc., Nihon Kohden Corporation, HeadSense Medical, Inc., Integra Life Sciences Corporation, Advanced Brain Monitoring, Inc., Elekta AB, Compumedics Germany GmbH, Natus Medical Incorporated, Compumedics, Ltd., Medtronic, Plc., CAS Medical Systems, Yokogawa Electric Corporation, MEG International Services Ltd., Electrical Geodesics, Inc., Cadwell Laboratories, Inc., Spiegelberg GmbH, Ornim Medical, Rimed, Inc., Vittamed Corporation, DePuy Synthes Companies, Third Eye Diagnostics, Inc., Masimo Corporation, NeuroWave Systems, Inc.,

Industry News:

Elekta has acquired 9 companies, including 3 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 3 assets. Elekta's largest acquisition to date was in 2011, when it acquired Nucletron B.V. for $411M. Elekta has acquired in 3 different US states, and 6 countries. The Company's most targeted sectors include healthcare services (34%) and medical products (23%).

Masimo has acquired 7 companies, including 4 in the last 5 years. A total of 2 acquisitions came from private equity firms. Masimo's largest acquisition to date was in 2022, when it acquired Sound United for $1.0B. Masimo has acquired in 2 different US states, and 4 countries. The Company's most targeted sectors include medical products (58%) and electronics (15%).

The Electroencephalography (EEG) Devices market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market, opportunities and upcoming challenges and about the competitors.

The Electroencephalography (EEG) Devices Market segments and Market Data Break Down are illuminated below

By Type:

Hospitals

Diagnostic Centers

Clinics

Others

By Application:

Standalone devices

Portable devices

The Electroencephalography (EEG) Devices market report highlights information regarding the current and future industry trends, growth patterns, as well as it offers business strategies to help the stakeholders in making sound decisions that may help to ensure the profit trajectory over the forecast years.

Have a query? Market an enquiry before purchase:

Following are the various regions covered by the Electroencephalography (EEG) Devices Market research report:

North America (the U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Russia, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, and Rest of APAC), South America (Brazil, Argentina, Columbia and Rest of Latin America), Middle East & Africa (Saudi Arabia, South Africa, Turkey, Nigeria, UAE and Rest of MEA)

Why is the United States Market Booming?

“Increasing Cases of Neurodegenerative Disorders”

The United States accounted for around 31.8% market share in the global market in 2023.

Growth is anticipated to be fueled by the increased incidence of different sleep and neurodegenerative disorders, accessibility, the presence of a highly developed healthcare infrastructure, and the nation's strong distribution and sales networks of top manufacturers.

Furthermore, the use of these devices for the diagnosis of neurological disorders has increased due to favourable reimbursement policies in the United States The rise of the United States market is also facilitated by the existence of governmental agencies such as the NINDS (National Institute of Neurological Disorders and Stroke), which provides funding for research and development activities relevant to the treatment of cognitive disorders.

Will the Germany Be a Lucrative Market for EEG Devices?

“Growing Number of Patients Suffering from Cognitive Disorders”

The Germany market held around 7.4% market share of the global market in 2023.

The rising prevalence of various cognitive disorders such as Alzheimer's disease and dementia in the German population coupled with rising awareness of brain function monitoring devices are expected factors to drive up the market in Germany throughout the forecast period.

For instance, according to Federal Ministry of Health (Germany), there are 1.6 million individuals currently living with dementia in Germany. Statistics show that one individual in every 25 households has dementia. By 2050, this number is expected to rise to 2.8 million.

Thus, the increasing patient pool suffering from disrupted brain functioning will create high demands for brain monitoring devices such as EEG devices.

How is China Emerging as a Prominent Market?

“Growing Elderly Population”

China held a market share of about 4.1% of the global market in 2023.

According to an article published in Scientific Journal, 2018, China's elderly population is increasing with a significant rate. One of the most prevalent health issues affecting the elderly population is cognitive impairment. According to estimates, more than 40% of elderly individuals 80 years and above believed to have cognitive impairment. Cognitive impairment increases the risk of disability and death. The prevalence of cognitive disorders in geriatric population is expected to propel the market further.

Key Points Covered in Market Report:

-Market Overview, Definition and Classification Market drivers and barriers

-Market Competition by Manufacturers

-Impact Analysis of COVID-19 on Market

-Market Capacity, Production, Revenue (Value) by region (2023-2029)

-Electroencephalography (EEG) Devices Supply (Production), Consumption, Export, Import by Region (2023-2029)

– Electroencephalography (EEG) Devices market Production, Revenue (Value), Price Trend by Type {Payment Gateway, Merchant Account, Subscription Management,}

-Electroencephalography (EEG) Devices Manufacturers Profiles/Analysis & Manufacturing Cost Analysis, Industrial/Supply Chain Analysis, Sourcing Strategy and Downstream Buyers, Marketing

-Strategy by Key Manufacturers/Players, Connected Distributors/Traders Standardization, Regulatory and collaborative initiatives, Industry Road map and value chain Market Effect Factors Analysis.

Buy Now Link:

Objectives of the Report

• To carefully analyses and forecast the size of the market by value and volume.
• To estimate the market shares of major segments of the Electroencephalography (EEG) Devices
• To showcase the development of the market in different parts of the world.
• To analyze and study micro-markets in terms of their contributions to the Electroencephalography (EEG) Devices market, their prospects, and individual growth trends.
• To offer precise and useful details about factors affecting the growth of the Electroencephalography (EEG) Devices
• To provide a meticulous assessment of crucial business strategies used by leading companies operating in the Electroencephalography (EEG) Devices market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches.

Can the Market Growth Be Affected in Any Way?

“High Production Cost and Current Limitations in Patient Scalability”

Comparing the spatial resolution of an EEG test to that of fMRI and EMG, two other methods of brain monitoring, is inadequate. Since measurements are being obtained at the scalp, a high number of neurons are present. Additionally, it makes it difficult to pinpoint the precise source of information or mental activity.

The presence of deep or minor lesions that cause inaccurate EEG results, the incorrect localization of the epileptogenic zone, the effects of hypoglycemia and alertness, and the short sampling period are some other drawbacks of EEG. All of the aforementioned drawbacks result in low spatial sampling and weak resolution, which limits the widespread use of EEG devices by consumers and medical professionals.

Key questions answered
– How feasible is Electroencephalography (EEG) Devices market for long-term investment?
– What are influencing factors driving the demand for Electroencephalography (EEG) Devices near future?
– What is the impact analysis of various factors in the Electroencephalography (EEG) Devices market growth?
– What are the recent trends in the regional Electroencephalography (EEG) Devices market and how successful they are?

We offer customization on the Electroencephalography (EEG) Devices market report based on specific client requirements:

MENAFN29032023004660010643ID1105893302